Prognostic Value of Adiponectin for Cardiovascular Disease and Mortality
Open accessThe DOI matches its Crossref record; 40 of the 40 references it cites were found in a registry or an index.
Abstract
CONTEXT: Low adiponectin concentrations are associated with the presence of an adverse cardiovascular disease (CVD) risk profile. OBJECTIVE: We studied the predictive value of adiponectin levels for all-cause and CVD mortality and CVD morbidity. DESIGN, SETTING, AND PARTICIPANTS: This was a population-based cohort study in Hoorn, The Netherlands, which started in 1989 and included 2484 participants, aged 50-75 yr. MAIN OUTCOME MEASURES: Hazard ratios (HRs) with 95% confidence interval per sd change in log-adiponectin for all-cause and CVD mortality and CVD morbidity were calculated. RESULTS: Adiponectin was determined for 1077 men and 1248 women. Higher adiponectin reduced the risk of nonfatal CVD in women [HR with 95% confidence interval 0.72 (0.61-0.90) in women and 0.92 (0.79-1.06) in men], but not the risk of all-cause or CVD mortality. In contrast, after adjustment for cardiovascular risk factors, higher adiponectin was a significant predictor of all-cause and CVD mortality [HR for CVD mortality 1.45 (1.10-1.92) in women and 1.30 (1.04-1.63) in men]. Higher adiponectin was associated with an increased risk of CVD mortality in people with prevalent CVD [HR 1.27 (0.98-1.63)] and with reduced risk in people without [HR 0.90 (0.73-1.11)]. After adjustment for cardiovascular risk factors, the HRs for CVD mortality were 1.60 (1.14-2.23) for patients with and 1.38 (1.06-1.80) for patients without prevalent CVD. CONCLUSIONS: High levels of adiponectin predict mortality, in particular in patients with prevalent CVD. We hypothesize that adiponectin protects against metabolic and vascular diseases, but in patients already afflicted with CVD, adiponectin is compensatory up-regulated and, therefore, indicates a high mortality risk.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Adiponectin and Adiponectin Receptors
Kadowaki, T., & Yamauchi, T. (2005) · Endocrine Reviews · doi:10.1210/er.2005-0005 · Cited by 2,634 · cited 10×
“There is growing evidence that reduced adiponectin concentrations indicate an increased cardiovascular risk because hypoadiponectinemia is associated with the components of the metabolic syndrome, in particular with insulin resistance, elevated triglycerides, and low high-density lipoprotein (HDL) ( 1 , 2). Apart from…”
BackgroundInfluentialPlasma Adiponectin Levels and Risk of Myocardial Infarction in Men
Pischon, T. (2004) · JAMA · doi:10.1001/jama.291.14.1730 · Cited by 1,773
Adiponectin acts in the brain to decrease body weight
Qi, Y., Takahashi, N., Hileman, S. M., Patel, H. R., Berg, A. H., Pajvani, U. B., Scherer, P. E., & Ahima, R. S. (2004) · Nature Medicine · doi:10.1038/nm1029 · Cited by 809
Zoccali, C., Mallamaci, F., Tripepi, G., Benedetto, F. A., Cutrupi, S., Parlongo, S., Malatino, L. S., Bonanno, G., Seminara, G., Rapisarda, F., et al. (2002) · Journal of the American Society of Nephrology · doi:10.1681/asn.v131134 · Cited by 761
Self-citationKalantar-Zadeh, K., Block, G., Horwich, T., & Fonarow, G. C. (2004) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2003.11.039 · Cited by 684
Plasma Adiponectin, Body Mass Index, and Mortality in Patients With Chronic Heart Failure
Kistorp, C., Faber, J., Galatius, S., Gustafsson, F., Frystyk, J., Flyvbjerg, A., & Hildebrandt, P. (2005) · Circulation · doi:10.1161/circulationaha.104.530972 · Cited by 605
Adiponectin Multimeric Complexes and the Metabolic Syndrome Trait Cluster
Lara-Castro, C., Luo, N., Wallace, P., Klein, R. L., & Garvey, W. T. (2006) · Diabetes · doi:10.2337/diabetes.55.01.06.db05-1105 · Cited by 480 · cited 1×
“Recent data indicatethatthehigh-molecularweightformisthemostactiveand clinically relevant form, at least for the metabolic and vascularprotective effects of adiponectin (1, 2, 38 , 39).”
BackgroundAdiponectin and Coronary Heart Disease: A Prospective Study and Meta-Analysis
Sattar, N., Wannamethee, G., Sarwar, N., Tchernova, J., Cherry, L., Wallace, A. M., Danesh, J., & Whincup, P. H. (2006) · Circulation · doi:10.1161/circulationaha.106.618918 · Cited by 403
Adiponectin and Future Coronary Heart Disease Events Among Men With Type 2 Diabetes
Schulze, M. B., Shai, I., Rimm, E. B., Li, T., Rifai, N., & Hu, F. B. (2005) · Diabetes · doi:10.2337/diabetes.54.2.534 · Cited by 365
Prevalence and Determinants of Glucose Intolerance in a Dutch Caucasian Population: The Hoorn Study
Mooy, J. M., Grootenhuis, P. A., Vries, H. D., Valkenburg, H. A., Bouter, L. M., Kostense, P. J., & Heine, R. J. (1995) · Diabetes Care · doi:10.2337/diacare.18.9.1270 · Cited by 323
Self-citation
Cited by
Obesity and inflammation: the linking mechanism and the complications
Ellulu, M. S., Patimah, I., Khaza’ai, H., Rahmat, A., & Abed, Y. (2017) · Archives of Medical Science · doi:10.5114/aoms.2016.58928 · Cited by 1,982
Sex differences in type 2 diabetes: focus on disease course and outcomes
Arnetz, L., Rajamand Ekberg, N., & Alvarsson, M. (2014) · Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy · doi:10.2147/dmso.s51301 · Cited by 175
“Low levels are a marker of insulin resistance,(63) whereas high levels have been associated with reduced risk of T2D(65) and CVD.(66)”
BackgroundInfluentialThe Adiponectin Paradox for All-Cause and Cardiovascular Mortality
Menzaghi, C., & Trischitta, V. (2018) · Diabetes · doi:10.2337/dbi17-0016 · Cited by 172
“Dekker, 2008 (72) General population (with no history of CVD) 1,886 340 ↔ General population (with history of CVD) 433 164 ↑”
BackgroundMenzaghi, C., Xu, M., Salvemini, L., De Bonis, C., Palladino, G., Huang, T., Copetti, M., Zheng, Y., Li, Y., Fini, G., et al. (2014) · Cardiovascular Diabetology · doi:10.1186/s12933-014-0130-y · Cited by 40
Metadata
- Authors
- Dekker, J. M., Funahashi, T., Nijpels, G., Pilz, S., Stehouwer, C. D. A., Snijder, M. B., Bouter, L. M., Matsuzawa, Y., Shimomura, I., & Heine, R. J.
- Venue
- The Journal of Clinical Endocrinology & Metabolism
- Publisher
- The Endocrine Society
- Published
- 2008-04
- Volume
- 93
- Issue
- 4
- Pages
- 1489-1496
- ISSN
- 0021-972X (ISSN-L)
- 1945-7197
- OpenAlex
- W2030260052
- Cited by
- 161
- References
- 40
- FWCI
- 11.61
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Prognostic Value of Adiponectin for Cardiovascular Disease and Mortality. https://app.cochat.ai/papers/10.1210/jc.2007-1436
- The paper
- Dekker, J. M., Funahashi, T., Nijpels, G., Pilz, S., Stehouwer, C. D. A., Snijder, M. B., Bouter, L. M., Matsuzawa, Y., Shimomura, I., & Heine, R. J. (2008). Prognostic Value of Adiponectin for Cardiovascular Disease and Mortality. The Journal of Clinical Endocrinology & Metabolism. https://doi.org/10.1210/jc.2007-1436
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.